Irvine News Today | 2 Min News | The Daily News Now!
President Trump secures a major deal with Regeneron, slashing prices on their drugs for Medicaid patients and offering Praluent at a discounted rate. The agreement includes a $27 billion investment in U.S. research, development, and manufacturing, and the approval of Otarmeni, a gene therapy for rare hearing loss in kids. Trump pitches this as a game-changer for economic relief, with plans to push Congress to make these deals permanent.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/364d1fc1c12eb295